Release Date: 20/01/12 10:06 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 81.08KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%